1. Baylor Institute for Immunology Research and Inserm U899, Dallas, TX;
2. Technion-Israel Institute of Technology, Technion City, Haifa, Israel;
3. Ecole doctorale Sciences de la Vie et de la Santé, Université Paris-Est, Créteil, France; and
4. Department of Gene and Cell Medicine and Department of Medicine (Clinical Immunology Division), Immunology Institute, Mount Sinai School of Medicine, New York, NY